Have your own idea? Try our Stock Screener
Polish (WIG) Pharma Industry Analysis
UpdatedJul 21, 2026
DataAggregated Company Financials
Companies6
- 7D6.5%
- 3M0.3%
- 1Y-12.9%
- YTD0.8%
Over the last 7 days, the Pharma industry has risen 5.8%, driven by gains from Celon Pharma of 7.6%. In the past year, the industry is down 13%. Looking forward, earnings are forecast to decline by 140% per year.
Industry Valuation and Performance
Has the Polish Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 21 Jul 2026 | zł1.3b | zł374.5m | zł92.0m | 10.2x | 14.5x | 3.6x |
| Thu, 18 Jun 2026 | zł1.3b | zł345.4m | -zł137,586,670.00 | 9.3x | -9.4x | 3.8x |
| Sat, 16 May 2026 | zł1.3b | zł349.9m | -zł137,593,990.00 | 10.4x | -9.5x | 3.7x |
| Mon, 13 Apr 2026 | zł1.3b | zł349.3m | -zł146,324,609.00 | 9.2x | -9x | 3.8x |
| Wed, 11 Mar 2026 | zł1.4b | zł349.2m | -zł146,238,953.00 | 10.1x | -9.3x | 3.9x |
| Fri, 06 Feb 2026 | zł1.4b | zł350.2m | -zł145,356,482.00 | 8.9x | -10x | 4.1x |
| Sun, 04 Jan 2026 | zł1.3b | zł350.2m | -zł145,356,482.00 | 9.3x | -9x | 3.8x |
| Tue, 02 Dec 2025 | zł1.4b | zł351.7m | -zł145,534,052.00 | 9.1x | -9.6x | 4x |
| Thu, 30 Oct 2025 | zł1.4b | zł327.7m | -zł93,055,146.00 | 9.8x | -15.1x | 4.3x |
| Sat, 27 Sep 2025 | zł1.4b | zł325.1m | -zł97,272,084.00 | 10.1x | -14.4x | 4.3x |
| Mon, 25 Aug 2025 | zł1.5b | zł333.5m | -zł72,391,353.00 | 10.4x | -20.4x | 4.4x |
| Wed, 23 Jul 2025 | zł1.5b | zł333.7m | -zł73,417,994.00 | 13x | -20.5x | 4.5x |
| Fri, 20 Jun 2025 | zł1.4b | zł333.7m | -zł73,417,994.00 | 13.8x | -18.9x | 4.2x |
| Sun, 18 May 2025 | zł1.6b | zł324.6m | -zł11,229,715.00 | 43.6x | -141x | 4.9x |
| Tue, 15 Apr 2025 | zł1.6b | zł324.0m | -zł12,792,856.00 | 43.6x | -125.2x | 4.9x |
| Thu, 13 Mar 2025 | zł1.7b | zł322.6m | -zł12,258,563.00 | 47.5x | -141x | 5.4x |
| Sat, 08 Feb 2025 | zł1.6b | zł318.9m | -zł9,295,998.00 | 42.9x | -169.7x | 4.9x |
| Mon, 06 Jan 2025 | zł1.7b | zł318.9m | -zł9,295,998.00 | 44.5x | -182.2x | 5.3x |
| Wed, 04 Dec 2024 | zł1.7b | zł360.7m | -zł14,404,163.00 | 44.3x | -120.1x | 4.8x |
| Fri, 01 Nov 2024 | zł1.7b | zł314.5m | -zł72,767,518.00 | 10.7x | -24x | 5.6x |
| Sun, 29 Sep 2024 | zł1.8b | zł314.9m | -zł71,339,104.00 | 11.4x | -25.5x | 5.8x |
| Tue, 27 Aug 2024 | zł2.1b | zł317.1m | -zł60,161,675.00 | 10.9x | -34.4x | 6.5x |
| Thu, 25 Jul 2024 | zł1.9b | zł310.8m | -zł61,217,640.00 | 11.7x | -31x | 6.1x |
| Sat, 22 Jun 2024 | zł1.1b | zł310.8m | -zł61,217,640.00 | 12x | -18.6x | 3.7x |
| Mon, 20 May 2024 | zł1.2b | zł315.1m | -zł43,109,632.00 | 12.4x | -28x | 3.8x |
| Wed, 17 Apr 2024 | zł1.1b | zł311.5m | -zł40,173,065.00 | 15.1x | -28.3x | 3.6x |
| Fri, 15 Mar 2024 | zł1.2b | zł311.5m | -zł40,173,065.00 | 15.2x | -29.8x | 3.8x |
| Sun, 11 Feb 2024 | zł1.2b | zł307.4m | -zł40,479,653.00 | 18x | -29.9x | 3.9x |
| Tue, 09 Jan 2024 | zł1.2b | zł308.7m | -zł39,880,934.00 | 11.7x | -30.2x | 3.9x |
| Thu, 07 Dec 2023 | zł1.2b | zł308.7m | -zł39,880,934.00 | 11.2x | -30.6x | 3.9x |
| Sat, 04 Nov 2023 | zł1.1b | zł302.0m | -zł44,782,495.00 | 11.2x | -25x | 3.7x |
| Mon, 02 Oct 2023 | zł1.1b | zł302.0m | -zł42,933,291.00 | 10.5x | -26.2x | 3.7x |
| Wed, 30 Aug 2023 | zł1.3b | zł287.0m | -zł53,882,152.00 | 11.4x | -23.4x | 4.4x |
| Fri, 28 Jul 2023 | zł1.2b | zł278.4m | -zł53,806,540.00 | 36.6x | -22.2x | 4.3x |
Price to Earnings Ratio
-22.2x
Current Industry PE
- Investors are pessimistic on the Polish Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 14.5x which is higher than its 3-year average PE of -40.9x.
- The 3-year average PS ratio of 4.3x is higher than the industry's current PS ratio of 3.6x.
Past Earnings Growth
- Total earnings for the Pharmaceuticals industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 10% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Trends
Which industries have driven the changes within the Polish Healthcare industry?
| PL Market | -0.51% | |
| Healthcare | -0.78% | |
| Pharma | 6.48% | |
| Pharma | 6.48% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CLN Celon Pharma | zł21.00 | 7.6% +zł79.7m | -12.5% | PE10.4x | |
| BGD Biogened | zł19.60 | 5.9% +zł2.7m | -27.9% | PE9.9x |